VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹113 Cr | ₹92 Cr | ₹53 Cr | ₹51 Cr | ₹50 Cr |
What is the latest Trade Payables ratio of VENUS REMEDIES ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹113 Cr |
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹53 Cr |
| Mar2023 | ₹51 Cr |
| Mar2022 | ₹50 Cr |
How is Trade Payables of VENUS REMEDIES Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹113 Cr | 23.54 | |
| Mar2025 | ₹92 Cr | 72.72 | |
| Mar2024 | ₹53 Cr | 4.61 | |
| Mar2023 | ₹51 Cr | 1.34 | |
| Mar2022 | ₹50 Cr | - | |
Compare Trade Payables of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,200.8 Cr | 1% | 7.3% | 239.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 1% |
7.3% |
239.3% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses